289 related articles for article (PubMed ID: 18580477)
1. Increased donor CD86+CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease.
Arpinati M; Chirumbolo G; Marzocchi G; Baccarani M; Rondelli D
Transplantation; 2008 Jun; 85(12):1826-32. PubMed ID: 18580477
[TBL] [Abstract][Full Text] [Related]
2. Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host disease.
Clark FJ; Freeman L; Dzionek A; Schmitz J; McMullan D; Simpson P; Mason J; Mahendra P; Craddock C; Griffiths M; Moss PA; Chakraverty R
Transplantation; 2003 Jan; 75(2):221-5. PubMed ID: 12548127
[TBL] [Abstract][Full Text] [Related]
3. Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation.
Arpinati M; Chirumbolo G; Urbini B; Bonifazi F; Bandini G; Saunthararajah Y; Zagnoli A; Stanzani M; Falcioni S; Perrone G; Tura S; Baccarani M; Rondelli D
Biol Blood Marrow Transplant; 2004 Feb; 10(2):106-15. PubMed ID: 14750076
[TBL] [Abstract][Full Text] [Related]
4. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
[TBL] [Abstract][Full Text] [Related]
5. Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors.
Arpinati M; Chirumbolo G; Saunthararajah Y; Stanzani M; Bonifazi F; Bandini G; Baccarani M; Rondelli D
Biol Blood Marrow Transplant; 2007 Feb; 13(2):228-34. PubMed ID: 17241928
[TBL] [Abstract][Full Text] [Related]
6. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.
Jun HX; Jun CY; Yu ZX
Haematologica; 2004 Dec; 89(12):1517-24. PubMed ID: 15590404
[TBL] [Abstract][Full Text] [Related]
7. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.
Balon J; Hałaburda K; Bieniaszewska M; Reichert M; Bieniaszewski L; Piekarska A; Pawłowski R; Hellmann A
Bone Marrow Transplant; 2005 Jun; 35(11):1083-8. PubMed ID: 15821766
[TBL] [Abstract][Full Text] [Related]
8. The functional immaturity of dendritic cells can be relevant to increased tolerance associated with cord blood transplantation.
Encabo A; Solves P; Carbonell-Uberos F; Miñana MD
Transfusion; 2007 Feb; 47(2):272-9. PubMed ID: 17302774
[TBL] [Abstract][Full Text] [Related]
9. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
[TBL] [Abstract][Full Text] [Related]
10. [Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic HLA mismatched/ haploidentical hematopoietic stem cell transplantation].
Wu JY; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):73-7. PubMed ID: 17650664
[TBL] [Abstract][Full Text] [Related]
11. Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease.
She K; Gilman AL; Aslanian S; Shimizu H; Krailo M; Chen Z; Reid GS; Wall D; Goldman F; Schultz KR
Biol Blood Marrow Transplant; 2007 Apr; 13(4):386-97. PubMed ID: 17382246
[TBL] [Abstract][Full Text] [Related]
12. Elevated numbers of immature/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease.
Greinix HT; Pohlreich D; Kouba M; Körmöczi U; Lohmann I; Feldmann K; Zielinski C; Pickl WF
Biol Blood Marrow Transplant; 2008 Feb; 14(2):208-19. PubMed ID: 18215781
[TBL] [Abstract][Full Text] [Related]
13. Predominant infiltration of monocytes in chronic graft-versus-host disease.
Namba N; Shinagawa K; Fujii N; Maeda Y; Ishimaru F; Ikeda K; Matsui T; Tanimoto M; Katayama Y
Transplantation; 2007 Jan; 83(2):220-4. PubMed ID: 17264819
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
Pavletic SZ; Smith LM; Bishop MR; Lynch JC; Tarantolo SR; Vose JM; Bierman PJ; Hadi A; Armitage JO; Kessinger A
Am J Hematol; 2005 Apr; 78(4):265-74. PubMed ID: 15795914
[TBL] [Abstract][Full Text] [Related]
15. Sequential analysis of HLA-C-specific killer cell inhibitory receptor (CD158b) expressing peripheral blood mononuclear cells during chronic graft-versus-host disease.
Tanaka J; Tutumi Y; Mori A; Ohta S; Kobayashi S; Asaka M; Imamura M
Bone Marrow Transplant; 2000 Aug; 26(3):287-90. PubMed ID: 10967567
[TBL] [Abstract][Full Text] [Related]
16. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Körholz D; Kunst D; Hempel L; Söhngen D; Heyll A; Bönig H; Göbel U; Zintl F; Burdach S
Bone Marrow Transplant; 1997 Apr; 19(7):691-5. PubMed ID: 9156246
[TBL] [Abstract][Full Text] [Related]
17. Activated circulating dendritic cells after hematopoietic stem cell transplantation predict acute graft-versus-host disease.
Lau J; Sartor M; Bradstock KF; Vuckovic S; Munster DJ; Hart DN
Transplantation; 2007 Apr; 83(7):839-46. PubMed ID: 17460553
[TBL] [Abstract][Full Text] [Related]
18. Chimerism does not influence graft-versus-myeloma and graft-versus-host disease in reduced intensity setting.
Galimberti S; Benedetti E; Morabito F; Fazzi R; Pacini S; Andreazzoli F; Martino M; Iacopino P; Petrini M
Transpl Immunol; 2005 Dec; 15(2):173-7. PubMed ID: 16412962
[TBL] [Abstract][Full Text] [Related]
19. Donor cell reaction to OKT3 as predictor of chronic graft-vs-host disease in hematopoietic stem cell recipients.
Lindemann M; Ottinger HD; Elmaagacli AH; Trenschel R; Rebmann V; Beelen DW; Grosse-Wilde H
Exp Hematol; 2006 Dec; 34(12):1753-8. PubMed ID: 17157173
[TBL] [Abstract][Full Text] [Related]
20. Plasmacytoid dendritic cell count on day 28 in HLA-matched related allogeneic peripheral blood stem cell transplant predicts the incidence of acute and chronic GVHD.
Rajasekar R; Mathews V; Lakshmi KM; Sellathamby S; George B; Viswabandya A; Daniel D; Chandy M; Srivastava A
Biol Blood Marrow Transplant; 2008 Mar; 14(3):344-50. PubMed ID: 18275901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]